Clinical Neuropsychopharmacology and Therapeutics
Online ISSN : 1884-8826
ISSN-L : 1884-8826
A Patient with Treatment-resistant Depression Who Achieved Remission with Heated Yoga: A Case Report
Hitoshi SakuraiMegha V. NagaswamiEmily K. TanAshley K. MeyerChris C. StreeterFelipe JainSimmie FosterAlbert YeungCristina CusinMaurizio FavaDavid MischoulonMaren B. Nyer
Author information
JOURNAL FREE ACCESS

2021 Volume 12 Pages 12-17

Details
Abstract

Novel interventions are needed to manage treatment-resistant depression (TRD), defined as patients who do not respond to two or more antidepressant trials of adequate dose and duration. We report on a 28-year-old female with TRD with nonresponse to several adequate trials of antidepressants who experienced full symptomatic remission after participating in the heated hatha yoga (HY) arm of a randomized controlled trial (RCT) for depression. Patients, including the one of interest, were randomized to 8 weeks of at least twice weekly HY or an 8-week waitlist followed by 8 weeks of HY. HY incorporates yoga plus heat through a series of standardized poses performed in a heated room (105°F). The 30-item Inventory of Depressive Symptoms, Clinician-Rated (IDS-C30) and 28-item Hamilton Depression Rating Scale (HAM-D28) were assessed at key time points throughout the study. The patient attended 16 classes over 8 weeks. Her baseline IDS-C30 score of 42 decreased to 26 following 2 weeks of HY, and continued declining throughout the intervention, with a final score of 6 (remission) after 8 weeks. HAM-D28 scores decreased from 26 at baseline to 4 (remission) after 8 weeks. At the 1-month follow-up, the patient's scores remained stable at 4 on IDS-C30 and 7 on HAM-D28, respectively. HY may serve as a potential intervention for TRD in patients who have not previously responded to conventional antidepressants. The rigorousness of the intervention must be considered regarding recommendations for use in the general population.

Content from these authors
© 2021 The Japanese Society of Clinical Neuropsychopharmacology
Previous article Next article
feedback
Top